Mátyus P
Semmelweis Egyetem, Szerves Vegytani Intézet, Budapest, Hógyes E. u. 7, H-1092.
Acta Pharm Hung. 2001;71(1):67-72.
The most significant achievements in the cardiovascular research areas have been reviewed. Among the beta-adrenoceptor blockers, antihypertensive, positive inotropic, and antiarrhythmic compounds synthesized and investigated at the IDR, a number of new drug candidates have been found and studied in clinical phases. One compound has been marketed (Tobanum, beta-adrenoceptor blocker).
心血管研究领域的重大成就已被综述。在药物研究与开发研究所合成并研究的β-肾上腺素受体阻滞剂、抗高血压药、正性肌力药和抗心律失常化合物中，已经发现了一些新的候选药物并进入临床研究阶段。有一种化合物已上市（托巴奴，β-肾上腺素受体阻滞剂）。
